Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02270359 · ClinicalTrials.gov registry record · NA

Research on Infarction With Open Arteries Using OCT and CMR

A NA study of Myocardial Infarction, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT02270359 is a NA study of Myocardial Infarction that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 15 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02270359, a NA study of Myocardial Infarction, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction (MI) and non-obstructive coronary artery disease (CAD) using optical coherence tomography (OCT). Additionally, cardiac magnetic resonance imaging (CMR) will be used to detect myocardial abnormalities, which will be correlated to OCT findings to gain insight into the mechanisms of MI in patients with non-obstructive coronary artery disease (i.e. "open arteries").

Conditions Studied

Interventions

  • DEVICE OCT
  • PROCEDURE CMR
  • DRUG contrast agent, Gadolinium

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-04
Est. Completion 2025-10-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02270359

The ClinicalTrials.gov registry entry for NCT02270359 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 3 interventions - of which OCT is the first listed.

NCT02270359 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02270359 about?

NCT02270359 is a clinical study titled "Research on Infarction With Open Arteries Using OCT and CMR". The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction (MI) and non-obstructive coronary artery disease (CAD) using optical coherence tomography (OCT). Additionally, cardiac magnetic reso...

What is the current status of trial NCT02270359?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2014-04. Estimated completion is 2025-10-31.

What conditions does trial NCT02270359 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT02270359?

The interventions under investigation include: OCT (DEVICE), CMR (PROCEDURE), contrast agent, Gadolinium (DRUG).

Who is sponsoring clinical trial NCT02270359?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02270359 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.